Pharmacogenomics Market Report by Technology (Polymerase Chain Reaction, Microarray, DNA Sequencing, Mass Spectrometry, Electrophoresis, and Others), Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Psychiatry, Pain Management, and Others), End User (Hospitals and Clinics, Academic and Research Institutes), and Region 2024-2032

Pharmacogenomics Market Report by Technology (Polymerase Chain Reaction, Microarray, DNA Sequencing, Mass Spectrometry, Electrophoresis, and Others), Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Psychiatry, Pain Management, and Others), End User (Hospitals and Clinics, Academic and Research Institutes), and Region 2024-2032

Report Format: PDF+Excel | Report ID: SR112024A4396
Buy Now

1   Preface
2   Scope and Methodology
    2.1    Objectives of the Study
    2.2    Stakeholders
    2.3    Data Sources
        2.3.1    Primary Sources
        2.3.2    Secondary Sources
    2.4    Market Estimation
        2.4.1    Bottom-Up Approach
        2.4.2    Top-Down Approach
    2.5    Forecasting Methodology
3   Executive Summary
4   Introduction
    4.1    Overview
    4.2    Key Industry Trends
5   Global Pharmacogenomics Market
    5.1    Market Overview
    5.2    Market Performance
    5.3    Impact of COVID-19
    5.4    Market Forecast
6   Market Breakup by Technology
    6.1    Polymerase Chain Reaction
        6.1.1 Market Trends
        6.1.2 Market Forecast
    6.2    Microarray
        6.2.1 Market Trends
        6.2.2 Market Forecast
    6.3    DNA Sequencing
        6.3.1 Market Trends
        6.3.2 Market Forecast
    6.4    Mass Spectrometry
        6.4.1 Market Trends
        6.4.2 Market Forecast
    6.5    Electrophoresis
        6.5.1 Market Trends
        6.5.2 Market Forecast
    6.6    Others
        6.6.1 Market Trends
        6.6.2 Market Forecast
7   Market Breakup by Application
    7.1    Oncology
        7.1.1 Market Trends
        7.1.2 Market Forecast
    7.2    Infectious Diseases
        7.2.1 Market Trends
        7.2.2 Market Forecast
    7.3    Cardiovascular Diseases
        7.3.1 Market Trends
        7.3.2 Market Forecast
    7.4    Neurological Diseases
        7.4.1 Market Trends
        7.4.2 Market Forecast
    7.5    Psychiatry
        7.5.1 Market Trends
        7.5.2 Market Forecast
    7.6    Pain Management
        7.6.1 Market Trends
        7.6.2 Market Forecast
    7.7    Others
        7.7.1 Market Trends
        7.7.2 Market Forecast
8   Market Breakup by End User
    8.1    Hospitals and Clinics
        8.1.1 Market Trends
        8.1.2 Market Forecast
    8.2    Academic and Research Institutes
        8.2.1 Market Trends
        8.2.2 Market Forecast
9   Market Breakup by Region
    9.1    North America
        9.1.1 United States
           9.1.1.1 Market Trends
           9.1.1.2 Market Forecast
        9.1.2 Canada
           9.1.2.1 Market Trends
           9.1.2.2 Market Forecast
    9.2    Asia-Pacific
        9.2.1 China
           9.2.1.1 Market Trends
           9.2.1.2 Market Forecast
        9.2.2 Japan
           9.2.2.1 Market Trends
           9.2.2.2 Market Forecast
        9.2.3 India
           9.2.3.1 Market Trends
           9.2.3.2 Market Forecast
        9.2.4 South Korea
           9.2.4.1 Market Trends
           9.2.4.2 Market Forecast
        9.2.5 Australia
           9.2.5.1 Market Trends
           9.2.5.2 Market Forecast
        9.2.6 Indonesia
           9.2.6.1 Market Trends
           9.2.6.2 Market Forecast
        9.2.7 Others
           9.2.7.1 Market Trends
           9.2.7.2 Market Forecast
    9.3    Europe
        9.3.1 Germany
           9.3.1.1 Market Trends
           9.3.1.2 Market Forecast
        9.3.2 France
           9.3.2.1 Market Trends
           9.3.2.2 Market Forecast
        9.3.3 United Kingdom
           9.3.3.1 Market Trends
           9.3.3.2 Market Forecast
        9.3.4 Italy
           9.3.4.1 Market Trends
           9.3.4.2 Market Forecast
        9.3.5 Spain
           9.3.5.1 Market Trends
           9.3.5.2 Market Forecast
        9.3.6 Russia
           9.3.6.1 Market Trends
           9.3.6.2 Market Forecast
        9.3.7 Others
           9.3.7.1 Market Trends
           9.3.7.2 Market Forecast
    9.4    Latin America
        9.4.1 Brazil
           9.4.1.1 Market Trends
           9.4.1.2 Market Forecast
        9.4.2 Mexico
           9.4.2.1 Market Trends
           9.4.2.2 Market Forecast
        9.4.3 Others
           9.4.3.1 Market Trends
           9.4.3.2 Market Forecast
    9.5    Middle East and Africa
        9.5.1 Market Trends
        9.5.2 Market Breakup by Country
        9.5.3 Market Forecast
10  SWOT Analysis
    10.1    Overview
    10.2    Strengths
    10.3    Weaknesses
    10.4    Opportunities
    10.5    Threats
11  Value Chain Analysis
12  Porters Five Forces Analysis
    12.1    Overview
    12.2    Bargaining Power of Buyers
    12.3    Bargaining Power of Suppliers
    12.4    Degree of Competition
    12.5    Threat of New Entrants
    12.6    Threat of Substitutes
13  Price Analysis
14  Competitive Landscape
    14.1    Market Structure
    14.2    Key Players
    14.3    Profiles of Key Players
        14.3.1    Abbott Laboratories
           14.3.1.1 Company Overview
           14.3.1.2 Product Portfolio
           14.3.1.3 Financials
           14.3.1.4 SWOT Analysis
        14.3.2    AstraZeneca plc
           14.3.2.1 Company Overview
           14.3.2.2 Product Portfolio
           14.3.2.3 Financials
           14.3.2.4 SWOT Analysis
        14.3.3    Bayer AG
           14.3.3.1 Company Overview
           14.3.3.2 Product Portfolio
           14.3.3.3 Financials
           14.3.3.4 SWOT Analysis
        14.3.4    Becton Dickinson and Company
           14.3.4.1 Company Overview
           14.3.4.2 Product Portfolio
           14.3.4.3 Financials
           14.3.4.4 SWOT Analysis
        14.3.5    Bio-Rad Laboratories Inc.
           14.3.5.1 Company Overview
           14.3.5.2 Product Portfolio
           14.3.5.3 Financials
           14.3.5.4 SWOT Analysis
        14.3.6    F. Hoffmann-La Roche AG
           14.3.6.1 Company Overview
           14.3.6.2 Product Portfolio
           14.3.6.3 SWOT Analysis
        14.3.7    GlaxoSmithKline plc
           14.3.7.1 Company Overview
           14.3.7.2 Product Portfolio
           14.3.7.3 Financials
           14.3.7.4 SWOT Analysis
        14.3.8    Illumina Inc.
           14.3.8.1 Company Overview
           14.3.8.2 Product Portfolio
           14.3.8.3 Financials
           14.3.8.4 SWOT Analysis
        14.3.9    Johnson & Johnson
           14.3.9.1 Company Overview
           14.3.9.2 Product Portfolio
           14.3.9.3 Financials
           14.3.9.4 SWOT Analysis
        14.3.10    Merck KGaA
           14.3.10.1 Company Overview
           14.3.10.2 Product Portfolio
           14.3.10.3 Financials
           14.3.10.4 SWOT Analysis
        14.3.11    Myriad Genetics Inc.
           14.3.11.1 Company Overview
           14.3.11.2 Product Portfolio
           14.3.11.3 Financials
           14.3.11.4 SWOT Analysis
        14.3.12    Qiagen N.V.
           14.3.12.1 Company Overview
           14.3.12.2 Product Portfolio
           14.3.12.3 Financials
           14.3.12.4 SWOT Analysis
        14.3.13    Thermo Fisher Scientific Inc
           14.3.13.1 Company Overview
           14.3.13.2 Product Portfolio
           14.3.13.3 Financials
           14.3.13.4 SWOT Analysis

List of Figures

Figure 1: Global: Pharmacogenomics Market: Major Drivers and Challenges
Figure 2: Global: Pharmacogenomics Market: Sales Value (in Billion US$), 2018-2023
Figure 3: Global: Pharmacogenomics Market Forecast: Sales Value (in Billion US$), 2024-2032
Figure 4: Global: Pharmacogenomics Market: Breakup by Technology (in %), 2023
Figure 5: Global: Pharmacogenomics Market: Breakup by Application (in %), 2023
Figure 6: Global: Pharmacogenomics Market: Breakup by End User (in %), 2023
Figure 7: Global: Pharmacogenomics Market: Breakup by Region (in %), 2023
Figure 8: Global: Pharmacogenomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
Figure 9: Global: Pharmacogenomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 10: Global: Pharmacogenomics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
Figure 11: Global: Pharmacogenomics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 12: Global: Pharmacogenomics (DNA Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
Figure 13: Global: Pharmacogenomics (DNA Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 14: Global: Pharmacogenomics (Mass Spectrometry) Market: Sales Value (in Million US$), 2018 & 2023
Figure 15: Global: Pharmacogenomics (Mass Spectrometry) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 16: Global: Pharmacogenomics (Electrophoresis) Market: Sales Value (in Million US$), 2018 & 2023
Figure 17: Global: Pharmacogenomics (Electrophoresis) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 18: Global: Pharmacogenomics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
Figure 19: Global: Pharmacogenomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 20: Global: Pharmacogenomics (Oncology) Market: Sales Value (in Million US$), 2018 & 2023
Figure 21: Global: Pharmacogenomics (Oncology) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 22: Global: Pharmacogenomics (Infectious Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 23: Global: Pharmacogenomics (Infectious Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 24: Global: Pharmacogenomics (Cardiovascular Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 25: Global: Pharmacogenomics (Cardiovascular Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 26: Global: Pharmacogenomics (Neurological Diseases) Market: Sales Value (in Million US$), 2018 & 2023
Figure 27: Global: Pharmacogenomics (Neurological Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 28: Global: Pharmacogenomics (Psychiatry) Market: Sales Value (in Million US$), 2018 & 2023
Figure 29: Global: Pharmacogenomics (Psychiatry) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 30: Global: Pharmacogenomics (Pain Management) Market: Sales Value (in Million US$), 2018 & 2023
Figure 31: Global: Pharmacogenomics (Pain Management) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 32: Global: Pharmacogenomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
Figure 33: Global: Pharmacogenomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 34: Global: Pharmacogenomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
Figure 35: Global: Pharmacogenomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 36: Global: Pharmacogenomics (Academic and Research Institutes) Market: Sales Value (in Million US$), 2018 & 2023
Figure 37: Global: Pharmacogenomics (Academic and Research Institutes) Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 38: North America: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 39: North America: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 40: United States: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 41: United States: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 42: Canada: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 43: Canada: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 44: Asia-Pacific: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 45: Asia-Pacific: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 46: China: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 47: China: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 48: Japan: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 49: Japan: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 50: India: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 51: India: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 52: South Korea: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 53: South Korea: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 54: Australia: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 55: Australia: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 56: Indonesia: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 57: Indonesia: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 58: Others: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 59: Others: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 60: Europe: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 61: Europe: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 62: Germany: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 63: Germany: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 64: France: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 65: France: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 66: United Kingdom: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 67: United Kingdom: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 68: Italy: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 69: Italy: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 70: Spain: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 71: Spain: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 72: Russia: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 73: Russia: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 74: Others: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 75: Others: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 76: Latin America: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 77: Latin America: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 78: Brazil: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 79: Brazil: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 80: Mexico: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 81: Mexico: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 82: Others: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 83: Others: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 84: Middle East and Africa: Pharmacogenomics Market: Sales Value (in Million US$), 2018 & 2023
Figure 85: Middle East and Africa: Pharmacogenomics Market: Breakup by Country (in %), 2023
Figure 86: Middle East and Africa: Pharmacogenomics Market Forecast: Sales Value (in Million US$), 2024-2032
Figure 87: Global: Pharmacogenomics Industry: SWOT Analysis
Figure 88: Global: Pharmacogenomics Industry: Value Chain Analysis
Figure 89: Global: Pharmacogenomics Industry: Porter's Five Forces Analysis

List of Tables

Table 1: Global: Pharmacogenomics Market: Key Industry Highlights, 2023 and 2032
Table 2: Global: Pharmacogenomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
Table 3: Global: Pharmacogenomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
Table 4: Global: Pharmacogenomics Market Forecast: Breakup by End User (in Million US$), 2024-2032
Table 5: Global: Pharmacogenomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
Table 6: Global: Pharmacogenomics Market: Competitive Structure
Table 7: Global: Pharmacogenomics Market: Key Players

Pharmacogenomics Market Report by Technology (Polymerase Chain Reaction, Microarray, DNA Sequencing, Mass Spectrometry, Electrophoresis, and Others), Application (Oncology, Infectious Diseases, Cardiovascular Diseases, Neurological Diseases, Psychiatry, Pain Management, and Others), End User (Hospitals and Clinics, Academic and Research Institutes), and Region 2024-2032
Purchase options




Inquire Before BuyingInquire Before Buying
Speak to an AnalystSpeak to an Analyst     
Request BrochureRequest Brochure         
Request CustomizationRequest Customization
Benefits of Customization

Personalize this research

Triangulate with your data

Get data as per your format and definition

Gain a deeper dive into a specific application, geography, customer, or competitor

Any level of personalization

Get in Touch With Us
UNITED STATES

Phone: +1-631-791-1145

INDIA

Phone: +91-120-433-0800

UNITED KINGDOM

Phone: +44-753-713-2163

Email: sales@imarcgroup.com

Client Testimonials

Aktive Services

IMARC made the whole process easy. Everyone I spoke with via email was polite, easy to deal with, kept their promises regarding delivery timelines and were solutions focused. From my first contact, I was grateful for the professionalism shown by the whole IMARC team. I recommend IMARC to all that need timely, affordable information and advice. My experience with IMARC was excellent and I can not fault it.

Read More
Greenfish S.A.

The IMARC team was very reactive and flexible with regard to our requests. A very good overall experience. We are happy with the work that IMARC has provided, very complete and detailed. It has contributed to our business needs and provided the market visibility that we required

Read More
Colruyt Group

We were very happy with the collaboration between IMARC and Colruyt. Not only were your prices competitive, IMARC was also pretty fast in understanding the scope and our needs for this project. Even though it was not an easy task, performing a market research during the COVID-19 pandemic, you were able to get us the necessary information we needed. The IMARC team was very easy to work with and they showed us that it would go the extra mile if we needed anything extra

Read More
KRISHAK BHARTI CO-OP LTD

Last project executed by your team was as per our expectations. We also would like to associate for more assignments this year. Kudos to your team.

Read More
Zee Media Corp. Ltd.

We would be happy to reach out to IMARC again, if we need Market Research/Consulting/Consumer Research or any associated service. Overall experience was good, and the data points were quite helpful.

Read More
Arabian Plastic Manufacturing Company Ltd.

The figures of market study were very close to our assumed figures. The presentation of the study was neat and easy to analyse. The requested details of the study were fulfilled. My overall experience with the IMARC Team was satisfactory.

Read More
Sumitomo Corporation

The overall cost of the services were within our expectations. I was happy to have good communications in a timely manner. It was a great and quick way to have the information I needed.

Read More
Hameln Rds

My questions and concerns were answered in a satisfied way. The costs of the services were within our expectations. My overall experience with the IMARC Team was very good.

Read More
Quality Consultants BV

I agree the report was timely delivered, meeting the key objectives of the engagement. We had some discussion on the contents, adjustments were made fast and accurate. The response time was minimum in each case. Very good. You have a satisfied customer.

Read More
TATA Advanced Systems Limited

We would be happy to reach out to IMARC for more market reports in the future. The response from the account sales manager was very good. I appreciate the timely follow ups and post purchase support from the team. My overall experience with IMARC was good.

Read More
Stax

IMARC was a good solution for the data points that we really needed and couldn't find elsewhere. The team was easy to work, quick to respond, and flexible to our customization requests.

Read More

Services

Industries

Industries

Quick Links

Contact us

United States

134 N 4th St. Brooklyn, NY 11249, USA

+1-631-791-1145

India

Level II & III, B-70, Sector 2, Noida, Uttar Pradesh 201301, India

+91-120-433-0800

United Kingdom

30 Churchill Place London E14 5EU, UK

+44-753-713-2163

Competitive Intelligence and Benchmarking Consumer Surveys and Feedback Reports Market Entry and Opportunity Assessment Pricing and Cost Research Procurement Research Report Store
Aerospace and Defense Agriculture Automotive BFSI Chemicals and Materials Construction and Manufacturing Electronics and Semiconductors Energy and Mining Food and Beverages Healthcare Packaging Retail Technology and Media Transportation and Logistics
Media Room Blogs Press Releases Our Customers Become a Publisher FAQ's

Contact us

United States

134 N 4th St. Brooklyn, NY 11249, USA

+1-631-791-1145

India

Level II & III, B-70 , Sector 2, Noida, Uttar Pradesh 201301, India

+91-120-433-0800

United Kingdom

30 Churchill Place London E14 5EU, UK

+44-753-713-2163

© Copyright IMARC Services Private Limited 2024. All rights reserved. Terms & Conditions | Privacy Policy | SiteMap